منابع مشابه
MDR TB Transmission, Singapore
To the Editor: Over the past decade, the proportion of pulmonary multidrug-resistant tuberculosis (MDR TB) cases among Singapore-born patients remained low, whereas that among foreign-born patients was 10 times higher (1,2). Since 2005, Singapore has experienced a sharp increase in the number of MDR TB cases from high-prevalence countries (3). We report local transmission of MDR TB in 2011, fro...
متن کاملMDR-TB and XDR-TB: drug resistance and treatment outcomes.
The subject is quite topical, as TB programmes and clinicians are searching for solutions to treat MDR/XDR-TB most effectively. Recently published studies and a systematic review have shown that XDR-TB is associated with higher probability of failure and death, and lower probability of treatment success than MDR-TB [2–7]. The XDR-TB-defining drugs have been studied to evaluate their role in det...
متن کاملMDR-/XDR-TB management: what it was, current standards and what is ahead.
Despite killing nearly 2 million people every year, TB is arguably the most neglected disease in terms of the funding and research it receives. In many ways, multidrug-resistant TB is a result of this disregard. In high-burden countries, not many improvements have been implemented in the diagnosis and treatment tools of TB since the 1960s. Following this period, fluoroquinolones, developed for ...
متن کاملMoxifloxacin Prophylaxis against MDR TB, New York, New York, USA
Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.
متن کاملNew WHO Europe action plan to fight MDR-TB.
As the multidrugand extensively drug-resistant tuberculosis (M/XDR-TB) is spreading at alarming rates in the World Health Organization (WHO) European Region – about 81,000 (18.4%) of the estimated 440,000 patients worldwide with MDR-TB are considered to live in this region – the WHO Regional Office for Europe has launched an action plan to contain the spread of drugresistant TB in the region by...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Breathe
سال: 2012
ISSN: 1810-6838
DOI: 10.1183/20734735.025312